Back | Next |
home / stock / amrx / amrx message board
Subject | By | Source | When |
---|---|---|---|
Lets see what these earnings dooo | Elpapibh | investorshub | 11/05/2020 8:52:01 PM |
Another snack of a close.!! Whos riding this | Elpapibh | investorshub | 11/04/2020 9:31:55 PM |
Fantastic close... | Elpapibh | investorshub | 11/02/2020 9:17:03 PM |
Did I jump on the train too late? | Elpapibh | investorshub | 10/28/2020 12:27:19 PM |
$AMRX could be a doubler by end of year! | ListenToMe | investorshub | 10/07/2020 4:11:11 PM |
Amneal is a solid company and will pay | ListenToMe | investorshub | 10/03/2020 1:19:19 PM |
With President Trump trying to bring $API manufacturing | Bngo | investorshub | 09/22/2020 2:11:25 PM |
Nice week $AMRX ?? | dangerx | investorshub | 09/19/2020 2:50:04 AM |
Shorts and scares. Plus the whole generic pharmaceutical | dangerx | investorshub | 09/15/2020 7:55:30 PM |
I agree $AMRX is a big Winner!! | ListenToMe | investorshub | 09/14/2020 6:23:16 PM |
This should be a good reason why Amneal | Bngo | investorshub | 09/14/2020 6:15:13 PM |
I like the company with its promising government | Bngo | investorshub | 09/14/2020 6:06:06 PM |
$AMRX is my fav. Pharma play. | ListenToMe | investorshub | 09/06/2020 5:33:11 PM |
$AMRX ... buy the dip. | ListenToMe | investorshub | 09/04/2020 7:21:29 PM |
$AMRX is a GREAT long-term play. | ListenToMe | investorshub | 09/02/2020 10:58:04 AM |
$AMRX has huge potential. Positioned perfectly to | ListenToMe | investorshub | 08/29/2020 12:44:44 PM |
I think institutional investors might come to play | dangerx | investorshub | 08/19/2020 10:22:50 PM |
#FACT...$182 was the price target last year for | ListenToMe | investorshub | 08/18/2020 11:36:53 PM |
As I was saying... $AMRX is quietly laying | ListenToMe | investorshub | 08/18/2020 1:12:23 PM |
$AMRX is just cruising along and laying low | ListenToMe | investorshub | 08/17/2020 12:46:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Amneal Pharmaceuticals Inc. Class A Website:
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...
FOCINVEZ (fosaprepitant) 150 mg/50 mL single dose vial is an anti-nausea agent for highly emetogenic and moderately emetogenic chemotherapy (HEC and MEC) Second injectable RTU product launched by Amneal in 2024 Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”...
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...